VC firm
Forty51 Ventures
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- Basel
- Founded
- 2022
- Latest fund size
- $15.1MSEC amount sold, as of 2022-05-16Source (opens in a new tab)
- Funds
- 1
Claim, correct or request removal
Record updated 27 September 2026
About
FORTY51 Ventures was founded in April 2022 as company builder and early stage investor of exceptional biotech companies in Europe with first or best-in-class potential.
Investment approach
- Thesis
- We invest in European early stage biotech opportunities with a clear path to the clinic, whether single-asset or platform. FORTY51 Ventures is the first institutional investor in your biotech company.Source (opens in a new tab)
- Eligibility
- Come and talk to us if you are a biotech entrepreneur in Europe or about to set-up your biotech company in Europe with great ambitions and well-differentiated, ground-breaking programs.
- Investing status notes
- Come and talk to us if you are a biotech entrepreneur in Europe or about to set-up your biotech company in Europe with great ambitions and well-differentiated, ground-breaking programs.
Funds
- Forty51 Ventures Fund I, SCSp, FIAR
- $15.1MVintage 2022, Main fund, SEC amount sold
Locations
- Headquarters
- Basel
Loading relationship preview